ES464729A1 - Benzisothiazolon process for preparing same and medical composition containing same - Google Patents
Benzisothiazolon process for preparing same and medical composition containing sameInfo
- Publication number
- ES464729A1 ES464729A1 ES464729A ES464729A ES464729A1 ES 464729 A1 ES464729 A1 ES 464729A1 ES 464729 A ES464729 A ES 464729A ES 464729 A ES464729 A ES 464729A ES 464729 A1 ES464729 A1 ES 464729A1
- Authority
- ES
- Spain
- Prior art keywords
- aryl
- alkyl
- opt
- same
- benzisothiazolon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Abstract
Benzisotheriazolones of formula (I) and their acid addn. salts when a basic N is present, are new. In the formula R1 and R2 are H, halo, 1-6C alkyl alkoxy, haloalkyl or alkanoylamino, NO2 or NH2 or together on adjacent C they are 3-6C alkylene or 1-3C oxyalkyleneoxy. X is 1-12C opt. branched alkylene, R3=H 1-6C alkyl, (opt. substD. by aryl or OH), 2-6C alkenyl, aryl or N-heterocyclyl, R4=1-6C alkyl (opt. substd. by aryl or OH), 2-6C alkenyl or aryl, or if R3 is not = H, also N-heterocyclyl. R3 and R4 are not both H or lower alkyl when R1 and R2 at positions 5 and 7 are H or halo, and X is lower alkylene. They are prepd. e.g. by reacting the corresp. N-H cpd. with Q.X.NR3R4(Q=easily eliminated gp. (I) are thrombocyte aggregation inhibitors so are useful for preventing or treating thrombosis in humans or animals. The pref. dose for adult humans is 10-500 mg orally 1-3 times per day. (I) can also be used to conserve blood in vitro, pref. at 0.01-50 mu g/ml.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB5064676 | 1976-12-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES464729A1 true ES464729A1 (en) | 1978-09-01 |
Family
ID=10456767
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES464729A Expired ES464729A1 (en) | 1976-12-04 | 1977-12-03 | Benzisothiazolon process for preparing same and medical composition containing same |
Country Status (12)
Country | Link |
---|---|
JP (1) | JPS5384969A (en) |
AR (1) | AR216841A1 (en) |
BE (1) | BE861326A (en) |
DE (1) | DE2753391A1 (en) |
DK (1) | DK539577A (en) |
ES (1) | ES464729A1 (en) |
FR (1) | FR2372816A1 (en) |
NL (1) | NL7713355A (en) |
PL (1) | PL202595A1 (en) |
PT (1) | PT67348B (en) |
SE (1) | SE7713711L (en) |
ZA (1) | ZA776857B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0000254B1 (en) * | 1977-06-20 | 1981-06-10 | Beecham Group Plc | Antithrombotic 2-(gamma-(1-piperidinyl)propyl)1,2-benzisothiazol 3-one, its pharmaceutically acceptable acid addition salts, their preparation and their compositions |
JPS58177915A (en) * | 1982-04-12 | 1983-10-18 | Green Cross Corp:The | Antithrombotic agent |
GB9626570D0 (en) * | 1996-12-20 | 1997-02-05 | Zeneca Ltd | Process for making benzisothiazolin-3-ones |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1147947B (en) * | 1961-07-25 | 1963-05-02 | Knoll Ag | Process for the preparation of new 1,2-benzisothiazolones |
-
1977
- 1977-11-16 ZA ZA00776857A patent/ZA776857B/en unknown
- 1977-11-29 BE BE183036A patent/BE861326A/en unknown
- 1977-11-30 PT PT67348A patent/PT67348B/en unknown
- 1977-11-30 DE DE19772753391 patent/DE2753391A1/en active Pending
- 1977-12-02 NL NL7713355A patent/NL7713355A/en not_active Application Discontinuation
- 1977-12-02 SE SE7713711A patent/SE7713711L/en unknown
- 1977-12-02 PL PL20259577A patent/PL202595A1/en unknown
- 1977-12-02 DK DK539577A patent/DK539577A/en unknown
- 1977-12-03 ES ES464729A patent/ES464729A1/en not_active Expired
- 1977-12-03 JP JP14560577A patent/JPS5384969A/en active Pending
- 1977-12-05 FR FR7736523A patent/FR2372816A1/en not_active Withdrawn
-
1979
- 1979-04-20 AR AR276256A patent/AR216841A1/en active
Also Published As
Publication number | Publication date |
---|---|
PT67348B (en) | 1979-04-26 |
SE7713711L (en) | 1978-06-05 |
JPS5384969A (en) | 1978-07-26 |
ZA776857B (en) | 1978-09-27 |
PL202595A1 (en) | 1978-10-09 |
AR216841A1 (en) | 1980-01-31 |
BE861326A (en) | 1978-05-29 |
FR2372816A1 (en) | 1978-06-30 |
DK539577A (en) | 1978-06-05 |
PT67348A (en) | 1977-12-01 |
DE2753391A1 (en) | 1978-06-08 |
NL7713355A (en) | 1978-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2006142A6 (en) | Quinolinecarboxylic acid derivatives. | |
IL79462A0 (en) | Bactericidal formulations containing quinolonecarboxylic acids and derivatives thereof for use in veterinary medicine | |
MX9203262A (en) | CHELATING AGENTS OF ACID 1,4,7,10-TETRAAZACICLODODECANO. | |
ATE38991T1 (en) | 2-POSITION-SUBSTITUTED 1,3PROPYLEDENDEPHOSPHONATE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
ES464729A1 (en) | Benzisothiazolon process for preparing same and medical composition containing same | |
ES2083983T3 (en) | SALTS OF ACID N5-N10-METHYLENE-5,6,7,8-TETRAHYDROPHOLIC. | |
ATE90673T1 (en) | ANTIFOLATE AGENT. | |
EP0446921A3 (en) | Optically active alkylene-dioxybenzene derivatives and their use in therapy | |
MY100483A (en) | Niflumic acid morpholinoethyl ester diniflumate, preparation, use in therapeutics as analgesic and anti- inflammatory | |
ES8801633A1 (en) | 3-Pyridylmethylnaphthyl derivatives, process for their preparation and their use as medicaments. | |
FR2694005B1 (en) | New aminoalkylchromones, methods for their preparation and pharmaceutical compositions containing them. | |
MY102275A (en) | Antimykotische aminoazole ii | |
ES8300709A1 (en) | Heterocyclic compounds, compositions thereof, their preparation and use. | |
FR2267102A1 (en) | 2,6-Di(branched alkylamino)pyridines - for treatment of fatty degeneration and diabetes | |
FR2363560A1 (en) | NEW COMPOUND WITH ANALGESIC ACTION AND THERAPEUTIC COMPOSITIONS IN CONTAINER | |
ES8104285A1 (en) | Clavulanic acid derivatives, their preparation and use in pharmaceutical compositions. | |
ATE1599T1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING 1,2,4-TRIAZOLYLENOL ETHER AND THEIR PREPARATION. | |
GB1530166A (en) | Adenine derivatives | |
GB2103215B (en) | Novel amidines, processes for their manufacture, pharmaceutical preparations containing them, and their use | |
ATE6514T1 (en) | CLAVULAN ACID DERIVATIVES, THEIR PRODUCTION AND PHARMACEUTICAL PREPARATIONS. | |
ES8107159A1 (en) | Lysine and arginine 5-(2,4-difluorophenyl)-2-hydrobenzoic acid salts, pharmaceutical compositions containing them and their use | |
EP0238814A3 (en) | Antibacterial medicaments for fish | |
DE3260244D1 (en) | 10b-carboxyamino boranes, process for their preparation and their use as medicaments in the neutron-capture therapy |